Related references
Note: Only part of the references are listed.Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab
David L. Lacey et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Intercellular Cross-Talk Among Bone Cells: New Factors and Pathways
Natalie A. Sims et al.
CURRENT OSTEOPOROSIS REPORTS (2012)
Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix
Hirohiko Okamura et al.
BONE (2011)
MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR
Jung Ha Kim et al.
CELLULAR SIGNALLING (2010)
NFATc1: Functions in osteoclasts
Qingxiao Zhao et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Upstream Stimulatory Factors Regulate OSCAR Gene Expression in RANKL-Mediated Osteoclast Differentiation
Jung Ha Kim et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Toll-like receptor 9 ligand blocks osteoclast differentiation through induction of phosphatase
Alla Amcheslavsky et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
The molecular understanding of osteoclast differentiation
Masataka Asagiri et al.
BONE (2007)
Biology of RANK, RANKL, and osteoprotegerin
Brendan F. Boyce et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Regulation of osteoblast differentiation by transcription factors
Toshihisa Komori
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides
A Amcheslavsky et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK
C. E. Evans et al.
BMC MUSCULOSKELETAL DISORDERS (2006)
Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis
K Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis
Y Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1
M Matsumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
H Takayanagi et al.
DEVELOPMENTAL CELL (2002)
Reaching a genetic and molecular understanding of skeletal development
G Karsenty et al.
DEVELOPMENTAL CELL (2002)
The ratio of messenger RNA levels of receptor activator of nuclear factor κB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis
NL Fazzalari et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
LC Hofbauer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Share Paper
